High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,568,949
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2026-02-17 | $319,963 | S | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2026-02-17 | $89,114 | S | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2026-02-17 | $162,501 | S | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
Other
|
2026-02-17 | $67,665 | M | Form 4 |
|
TERN
S
Terns Pharmaceuticals, Inc.
Burroughs Amy L.
• CEO
10b5-1 SellΔOwn -17.1%
2026-01-15
$2,266,373Large
|
||||||
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
10b5-1 SellΔOwn -17.1%
|
2026-01-15 | $2,266,373Large | S | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
Other
|
2026-01-15 | $125,665 | M | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
Other
|
2026-01-15 | $67,665 | M | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2026-01-15 | $282,230 | S | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
Director
Other
|
2025-11-04 | $226,565 | M | Form 4 |
| TERN |
Terns Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-11-04 | $441,360 | S | Form 4 |
|
TERN
S
Terns Pharmaceuticals, Inc.
Kuriakose Emil
• Officer • Chief Medical Officer
Discretionary Sell
2025-10-01
$7,407
|
||||||
| TERN |
Terns Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary Sell
|
2025-10-01 | $7,407 | S | Form 4 |